Γ

SynBioBeta Speaker

Simone Bianco

Altos Labs

VP, Physics, Molecular & Hybrid Modeling

Dr. Simone Bianco is Vice President of Hybrid AI and Physics Based modeling at the Altos Labs Institute of Computation. Prior to joining Altos, he was a research staff member and manager of the department of Functional Genomics and Cellular Engineering at the IBM Almaden Research Center. He is an expert in computer driven design of biological systems. Dr. Bianco has contributed to the design of vaccines, antivirals, antimicrobials and immunotherapies, and holds several patents in synthetic biology. He is founding PI of the NSF Center for Cellular Construction, which aims at transforming cell biology into an engineering discipline. Dr. Bianco is a TED speaker with over 1M views, recipient of IBM’s Outstanding Research Achievement Award, and an honorary visiting lecturer for the Society for Industrial and Applied Mathematics, for his standing in the field of dynamical systems and commitment to education.

Sessions Featuring

Simone

This Year

Breakout Session

3:30 PM

-

4:15 PM

Longevity

Engineering Longevity: Reprogramming the Foundations of Aging

Aging is increasingly understood as a gradual loss of biological stability. DNA accumulates damage, protein homeostasis collapses, and cells drift away from youthful identities as regulatory networks lose their balance over time. These changes ripple across tissues and organs, driving many of the diseases associated with aging. Today, new tools in synthetic biology, artificial intelligence, and gene editing are revealing how these systems might be stabilized, repaired, or even reset. Researchers are engineering enhanced DNA repair mechanisms inspired by long-lived species, using AI to map the trajectories of cellular aging and uncover rejuvenating interventions, and developing therapies that restore protein metabolism to protect vulnerable tissues such as the brain. This session explores how scientists are moving beyond simply slowing aging to engineering the biological systems that maintain cellular integrity. By targeting the underlying mechanisms that govern genome stability, proteostasis, and cellular identity, researchers are laying the groundwork for a new generation of longevity therapeutics designed to restore function and resilience across the lifespan.

Breakout Session

3:30 PM

-

4:15 PM

Longevity

Engineering Longevity: Reprogramming the Foundations of Aging

Aging is increasingly understood as a gradual loss of biological stability. DNA accumulates damage, protein homeostasis collapses, and cells drift away from youthful identities as regulatory networks lose their balance over time. These changes ripple across tissues and organs, driving many of the diseases associated with aging. Today, new tools in synthetic biology, artificial intelligence, and gene editing are revealing how these systems might be stabilized, repaired, or even reset. Researchers are engineering enhanced DNA repair mechanisms inspired by long-lived species, using AI to map the trajectories of cellular aging and uncover rejuvenating interventions, and developing therapies that restore protein metabolism to protect vulnerable tissues such as the brain. This session explores how scientists are moving beyond simply slowing aging to engineering the biological systems that maintain cellular integrity. By targeting the underlying mechanisms that govern genome stability, proteostasis, and cellular identity, researchers are laying the groundwork for a new generation of longevity therapeutics designed to restore function and resilience across the lifespan.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include